Tizanidine Hydrochloride (Jubilant Cadista Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Tizanidine Hydrochloride drug offered from Jubilant Cadista Pharmaceuticals Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Jubilant Cadista Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Tizanidine Hydrochloride
SUBSTANCE NAME: TIZANIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-08-04
END MARKETING DATE: 0000-00-00


Tizanidine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTizanidine Hydrochloride from Jubilant Cadista Pharmaceuticals Inc.
LABELER NAME: Jubilant Cadista Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 2017-08-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59746-670_b384b1a9-6301-4d3f-a6f1-4deb5f58e6e6
PRODUCT NDC: 59746-670
APPLICATION NUMBER: ANDA209605

Other TIZANIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Jubilant Cadista Pharmaceuticals Inc.Tizanidine Hydrochloride
New Horizon Rx Group, LLCTizanidine